Complete Filing Data
Schrodinger, Inc. reported Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax of -$113.0 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Schrodinger, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$103.3M | -$187.1M | $40.7M | -$149.2M | -$100.4M | -$24.5M | -$24.6M |
| Revenue * | $255.9M | $207.5M | $216.7M | $181.0M | $137.9M | $108.1M | $85.5M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$113.0K | -$61.0K | $2.7M | -$1.7M | -$968.0K | $301.0K | $25.0K |
| Selling And Marketing Expense | $41.0M | $39.9M | $37.2M | $30.6M | $22.2M | $17.8M | $21.4M |
| Research And Development Expense | $173.1M | $201.8M | $181.8M | $126.4M | $90.9M | $64.7M | $39.4M |
| Operating Income Loss | -$166.9M | -$209.3M | -$177.4M | -$146.8M | -$111.4M | -$60.9M | -$38.7M |
| Operating Expenses | $309.5M | $341.4M | $318.1M | $247.8M | $177.1M | $124.4M | $87.8M |
| Nonoperating Income Expense | $64.6M | $23.6M | $220.4M | -$2.3M | $10.6M | $34.6M | $12.7M |
| Income Tax Expense Benefit | $939.0K | $1.4M | $2.2M | $63.0K | $411.0K | $345.0K | -$291.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$102.3M | -$185.7M | $42.9M | -$149.1M | -$100.8M | -$26.3M | -$26.0M |
| Gross Profit | $142.6M | $132.1M | $140.7M | $101.0M | $65.6M | $63.5M | $49.1M |
| General And Administrative Expense | $95.4M | $99.7M | $99.1M | $90.8M | $64.0M | $41.9M | $27.0M |
| Cost Of Revenue | $113.3M | $75.5M | $76.0M | $79.9M | $72.3M | $44.6M | $36.5M |
| Comprehensive Income Net Of Tax | -$103.4M | -$187.2M | $43.4M | -$150.9M | -$101.4M | -$24.2M | -$24.5M |
| Income Loss From Equity Method Investments | $0.00 | $0.00 | $147.2M | $11.8M | -$1.8M | $4.1M | $943.0K |
| Other Nonoperating Income Expense | $16.4M | $17.9M | $19.7M | $4.0M | $1.1M | $2.3M | |
| Income Taxes Paid Net | $1.1M | $2.8M | $787.0K | $448.0K | $381.0K | $139.0K | |
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | -$3.0K | -$826.0K | -$2.2M | -$1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$32.8M | -$43.2M | -$59.8M | -$38.1M | -$54.0M | -$54.7M | -$62.0M | $4.3M | $129.1M | -$39.9M | -$47.7M | -$34.4M | -$35.0M | -$34.6M | -$29.0K | $3.9M | -$3.4M | -$13.8M | -$11.5M | -$500.0K | -$5.8M |
| Revenue * | $54.3M | $54.8M | $59.6M | $35.3M | $47.3M | $36.6M | $42.6M | $35.2M | $64.8M | $37.0M | $38.5M | $48.7M | $29.9M | $29.8M | $32.1M | $25.8M | $23.1M | $26.2M | $20.0M | $19.0M | $20.7M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $108.0K | -$119.0K | -$130.0K | $777.0K | -$108.0K | -$353.0K | $192.0K | $216.0K | $1.5M | -$283.0K | -$746.0K | -$2.0M | -$32.0K | -$1.0K | -$240.0K | -$247.0K | $1.2M | -$458.0K | $5.0K | $18.0K | $10.0K |
| Selling And Marketing Expense | $9.5M | $10.7M | $10.4M | $10.3M | $9.7M | $10.2M | $9.1M | $9.0M | $9.1M | $7.2M | $7.4M | $6.7M | $5.6M | $5.4M | $5.2M | $4.0M | $4.4M | $4.8M | $5.2M | $5.3M | $5.1M |
| Research And Development Expense | $42.8M | $43.1M | $45.8M | $51.0M | $50.8M | $50.6M | $46.8M | $42.7M | $40.7M | $32.9M | $31.1M | $27.8M | $23.2M | $21.1M | $21.4M | $17.0M | $16.7M | $13.7M | $10.4M | $9.5M | $8.4M |
| Operating Income Loss | -$45.9M | -$52.9M | -$50.9M | -$68.4M | -$52.7M | -$67.4M | -$56.2M | -$61.1M | -$30.5M | -$46.2M | -$43.5M | -$28.6M | -$34.7M | -$30.3M | -$23.9M | -$15.4M | -$17.1M | -$11.8M | -$11.3M | -$14.0M | -$5.6M |
| Operating Expenses | $74.0M | $79.1M | $82.0M | $86.2M | $84.1M | $86.3M | $79.8M | $74.9M | $76.2M | $63.4M | $60.6M | $56.6M | $45.8M | $42.3M | $40.1M | $30.7M | $30.7M | $27.4M | $22.0M | $23.8M | $18.6M |
| Nonoperating Income Expense | $13.3M | $10.0M | -$8.9M | $30.2M | -$1.2M | $13.2M | -$8.7M | $45.0M | $186.0M | $6.5M | -$4.2M | -$5.8M | -$341.0K | -$4.6M | $23.5M | $18.7M | $13.1M | -$2.4M | -$926.0K | $13.2M | -$189.0K |
| Income Tax Expense Benefit | $162.0K | $287.0K | $28.0K | -$90.0K | $83.0K | $456.0K | -$2.9M | -$20.4M | $26.4M | $194.0K | $33.0K | -$28.0K | -$4.0K | $67.0K | $74.0K | -$35.0K | $64.0K | $91.0K | -$257.0K | -$51.0K | $46.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$32.6M | -$42.9M | -$59.8M | -$38.2M | -$54.0M | -$54.3M | -$64.9M | -$16.2M | $155.5M | -$39.7M | -$47.7M | -$34.5M | -$35.0M | -$34.9M | -$449.0K | $3.3M | -$4.0M | -$14.2M | -$12.2M | -$778.0K | -$5.8M |
| Gross Profit | $28.0M | $26.2M | $31.1M | $17.7M | $31.3M | $18.9M | $23.6M | $13.8M | $45.7M | $17.2M | $17.1M | $28.0M | $11.1M | $12.0M | $16.2M | $15.3M | $13.6M | $15.6M | $10.7M | $9.9M | $13.0M |
| General And Administrative Expense | $21.7M | $25.2M | $25.8M | $24.8M | $23.5M | $25.5M | $23.9M | $23.2M | $26.3M | $23.3M | $22.1M | $22.1M | $17.0M | $15.9M | $13.4M | $9.7M | $9.7M | $8.9M | $6.5M | $8.9M | $5.1M |
| Cost Of Revenue | $26.3M | $28.6M | $28.4M | $17.6M | $16.0M | $17.7M | $18.9M | $21.4M | $19.1M | $19.8M | $21.3M | $20.7M | $18.7M | $17.8M | $16.0M | $10.5M | $9.5M | $10.5M | $9.2M | $9.2M | $7.7M |
| Comprehensive Income Net Of Tax | -$32.7M | -$43.3M | -$59.9M | -$37.4M | -$54.2M | -$55.1M | -$61.8M | $4.5M | $130.6M | -$40.1M | -$48.4M | -$36.4M | -$35.0M | -$34.6M | -$269.0K | $3.6M | -$2.2M | -$14.3M | -$11.5M | -$482.0K | -$5.8M |
| Income Loss From Equity Method Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $147.3M | -$3.0K | $11.8M | $0.00 | $0.00 | -$1.8M | $4.2M | ||||||
| Other Nonoperating Income Expense | $3.6M | $5.4M | $4.2M | $4.7M | $4.6M | $5.0M | $5.8M | $4.3M | $2.9M | $1.2M | -$308.0K | $339.0K | $286.0K | $357.0K | |||||||
| Income Taxes Paid Net | $139.0K | $180.0K | $86.0K | $37.0K | $119.0K | $64.0K | $62.0K | ||||||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | -$3.0K | $12.0K | -$11.0K | -$4.0K | -$326.0K | -$494.0K | -$566.0K | -$716.0K | -$445.0K | -$453.0K | -$227.0K | -$54.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $364.1M | $421.4M | $548.6M | $447.9M | $557.1M | $624.0M | -$93.4M | -$71.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $237.4M | $162.7M | $161.1M | $95.7M | $123.3M | $202.8M | $26.5M | $77.7M |
| Unbilled And Other Receivables Current | $21.4M | $19.6M | $23.1M | $13.1M | $8.8M | $4.0M | $7.1M | |
| Retained Earnings Accumulated Deficit | -$628.8M | -$525.5M | -$338.4M | -$379.1M | -$230.0M | -$129.6M | -$105.1M | |
| Restricted Cash Current | $6.9M | $15.3M | $5.8M | $5.2M | $3.0M | $500.0K | $500.0K | |
| Other Liabilities Noncurrent | $1.3M | $146.0K | $667.0K | $800.0K | $300.0K | $654.0K | $900.0K | |
| Other Assets Noncurrent | $6.3M | $4.2M | $6.0M | $3.3M | $2.9M | $2.4M | $2.3M | |
| Other Accrued Liabilities Current | $9.2M | $10.3M | $12.0M | $5.5M | $7.3M | $2.9M | $3.8M | |
| Operating Lease Right Of Use Asset | $102.7M | $111.9M | $117.8M | $106.0M | $75.4M | $10.1M | $12.8M | |
| Operating Lease Liability Noncurrent | $92.8M | $101.1M | $111.0M | $105.5M | $77.8M | $7.2M | $8.9M | |
| Operating Lease Liability Current | $16.4M | $16.8M | $16.9M | $11.0M | $2.0M | $4.5M | $5.6M | |
| Marketable Securities Current | $164.9M | $204.8M | $307.7M | $360.6M | $456.2M | $440.4M | $59.8M | |
| Liabilities Current | $189.1M | $191.7M | $133.7M | $108.8M | $91.2M | $73.2M | $45.0M | |
| Liabilities And Stockholders Equity | $726.2M | $823.2M | $803.0M | $688.6M | $756.5M | $746.3M | $155.3M | |
| Liabilities | $362.1M | $401.8M | $254.4M | $240.7M | $199.4M | $122.2M | $57.0M | |
| Equity Method Investments | $73.6M | $43.2M | $83.3M | $25.7M | $43.2M | $45.7M | $15.4M | |
| Cash And Cash Equivalents At Carrying Value | $230.5M | $147.3M | $155.3M | $90.5M | $120.3M | $202.3M | $26.0M | |
| Assets Current | $519.3M | $635.0M | $567.8M | $534.0M | $625.1M | $683.0M | $118.5M | |
| Assets | $726.2M | $823.2M | $803.0M | $688.6M | $756.5M | $746.3M | $155.3M | |
| Allowance For Doubtful Accounts Receivable Current | $440.0K | $210.0K | $220.0K | $125.0K | $108.0K | $60.0K | $50.0K | |
| Additional Paid In Capital Common Stock | $992.0M | $946.0M | $886.0M | $828.7M | $787.0M | $752.6M | $11.7M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $107.0K | $220.0K | $281.0K | -$2.4M | -$651.0K | $317.0K | $16.0K | |
| Accrued Payroll Taxes Current | $39.3M | $42.1M | $31.8M | $24.9M | $18.4M | $12.0M | $7.0M | |
| Accounts Receivable Net Current | $83.0M | $235.7M | $66.0M | $56.0M | $31.7M | $31.4M | $18.7M | |
| Accounts Payable Current | $11.5M | $10.7M | $16.8M | $9.5M | $8.1M | $8.4M | $3.5M | |
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 | $81.0K | $157.0K | $457.0K | $293.0K | $0.00 | $0.00 | $90.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$79.5M | $176.3M | -$51.2M | |||||
| Allowance For Unbilled Receivables Current | $140.0K | $100.0K | $100.0K | $100.0K | $30.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $321.4M | $342.9M | $373.5M | $449.4M | $474.0M | $513.7M | $548.6M | $563.6M | $611.2M | $590.3M | $447.9M | $463.1M | $493.1M | $530.7M | $579.8M | $605.8M | $631.8M | $630.9M | $296.1M | $295.5M | -$87.2M | -$76.6M | -$76.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $181.9M | $232.0M | $337.8M | $170.2M | $112.3M | $134.9M | $255.6M | $291.0M | $237.7M | $108.6M | $130.8M | $120.8M | $163.9M | $120.7M | $133.6M | $211.0M | $110.9M | $145.2M | $33.1M | $44.5M | $62.2M | ||
| Unbilled And Other Receivables Current | $28.0M | $26.7M | $26.0M | $31.5M | $40.3M | $25.8M | $12.3M | $14.6M | $13.5M | $12.2M | $13.0M | $16.3M | $5.0M | $4.5M | $7.0M | $4.9M | $3.3M | $1.9M | |||||
| Retained Earnings Accumulated Deficit | -$661.3M | -$628.5M | -$585.3M | -$485.3M | -$447.2M | -$393.1M | -$307.7M | -$245.7M | -$250.0M | -$351.9M | -$312.1M | -$264.4M | -$199.2M | -$164.2M | -$129.6M | -$118.4M | -$122.3M | -$118.9M | |||||
| Restricted Cash Current | $9.8M | $12.1M | $11.8M | $9.8M | $4.2M | $4.6M | $6.2M | $5.1M | $4.5M | $5.8M | $3.5M | $3.5M | $3.0M | $3.0M | $500.0K | $500.0K | $500.0K | $500.0K | |||||
| Other Liabilities Noncurrent | $111.0K | $136.0K | $155.0K | $297.0K | $424.0K | $545.0K | $707.0K | $600.0K | $700.0K | $900.0K | $1.0M | $1.4M | $300.0K | $300.0K | $600.0K | $600.0K | $600.0K | $900.0K | |||||
| Other Assets Noncurrent | $6.9M | $5.7M | $4.6M | $5.2M | $3.6M | $3.2M | $7.4M | $5.1M | $6.2M | $2.9M | $1.8M | $1.3M | $4.0M | $3.4M | $2.4M | $2.2M | $2.1M | $2.2M | |||||
| Other Accrued Liabilities Current | $8.9M | $10.3M | $9.9M | $7.6M | $9.7M | $10.6M | $8.5M | $7.3M | $8.6M | $6.4M | $9.2M | $6.9M | $4.8M | $7.3M | $5.7M | $2.2M | $2.8M | $3.2M | |||||
| Operating Lease Right Of Use Asset | $105.1M | $107.3M | $109.7M | $112.8M | $116.5M | $118.6M | $119.8M | $113.0M | $106.0M | $88.5M | $90.1M | $78.1M | $76.5M | $7.5M | $8.9M | $10.6M | $11.9M | $13.2M | |||||
| Operating Lease Liability Noncurrent | $94.7M | $97.5M | $99.4M | $103.3M | $107.1M | $109.0M | $112.7M | $107.3M | $104.1M | $87.2M | $88.1M | $77.4M | $77.1M | $6.4M | $6.8M | $6.8M | $7.8M | $9.1M | |||||
| Operating Lease Liability Current | $16.7M | $16.8M | $16.8M | $16.9M | $16.8M | $16.9M | $16.3M | $13.9M | $11.8M | $8.7M | $7.2M | $4.2M | $2.0M | $2.5M | $3.6M | $5.5M | $5.8M | $5.9M | |||||
| Marketable Securities Current | $219.1M | $230.3M | $174.3M | $228.3M | $269.2M | $300.8M | $246.9M | $262.7M | $294.5M | $370.7M | $382.2M | $408.3M | $436.3M | $495.9M | $515.4M | $388.5M | $173.6M | $143.5M | |||||
| Liabilities Current | $145.1M | $155.8M | $165.5M | $111.1M | $99.8M | $106.5M | $105.0M | $106.8M | $123.4M | $88.8M | $85.6M | $85.5M | $72.9M | $70.4M | $67.6M | $39.3M | $43.0M | $42.2M | |||||
| Liabilities And Stockholders Equity | $653.7M | $688.2M | $743.0M | $669.3M | $688.4M | $737.8M | $794.1M | $841.6M | $838.8M | $662.0M | $687.9M | $719.5M | $762.6M | $717.3M | $744.2M | $680.1M | $349.6M | $349.9M | |||||
| Liabilities | $332.3M | $345.4M | $369.5M | $219.9M | $214.4M | $224.1M | $230.6M | $230.3M | $248.5M | $198.9M | $194.8M | $188.9M | $182.8M | $111.6M | $112.4M | $49.2M | $53.4M | $54.3M | |||||
| Equity Method Investments | $44.4M | $34.7M | $30.1M | $65.2M | $88.6M | $91.4M | $91.9M | $106.4M | $101.5M | $27.2M | $21.9M | $37.0M | $51.1M | $49.7M | $52.9M | $40.9M | $22.7M | $15.2M | |||||
| Cash And Cash Equivalents At Carrying Value | $172.1M | $219.9M | $326.0M | $160.4M | $108.1M | $130.2M | $249.4M | $286.0M | $233.2M | $102.8M | $127.3M | $117.3M | $160.9M | $117.7M | $133.1M | $210.5M | $110.4M | $144.7M | |||||
| Assets Current | $471.7M | $514.0M | $570.9M | $456.4M | $449.2M | $493.7M | $547.8M | $592.0M | $603.7M | $524.2M | $556.9M | $586.2M | $622.0M | $649.8M | $675.2M | $621.1M | $307.0M | $312.8M | |||||
| Assets | $653.7M | $688.2M | $743.0M | $669.3M | $688.4M | $737.8M | $794.1M | $841.6M | $838.8M | $662.0M | $687.9M | $719.5M | $762.6M | $717.3M | $744.2M | $680.1M | $349.6M | $349.9M | |||||
| Allowance For Doubtful Accounts Receivable Current | $420.0K | $350.0K | $210.0K | $250.0K | $150.0K | $130.0K | $150.0K | $250.0K | $125.0K | $124.0K | $124.0K | $127.0K | $108.0K | $110.0K | $60.0K | $50.0K | $50.0K | $50.0K | |||||
| Additional Paid In Capital Common Stock | $981.9M | $970.7M | $958.0M | $933.4M | $920.6M | $906.2M | $871.1M | $856.9M | $840.4M | $818.0M | $807.8M | $797.0M | $778.3M | $769.2M | $760.6M | $748.1M | $417.0M | $414.2M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $79.0K | -$29.0K | $90.0K | $597.0K | -$180.0K | -$72.0K | -$491.0K | -$683.0K | -$899.0K | -$3.7M | -$3.4M | -$2.7M | $44.0K | $76.0K | $77.0K | $480.0K | $727.0K | -$442.0K | |||||
| Accrued Payroll Taxes Current | $28.0M | $25.3M | $21.5M | $33.6M | $24.3M | $19.5M | $25.5M | $21.3M | $13.2M | $18.9M | $16.5M | $11.0M | $14.0M | $10.5M | $10.3M | $7.7M | $5.8M | $4.7M | |||||
| Accounts Receivable Net Current | $29.4M | $10.1M | $20.3M | $13.3M | $11.8M | $19.8M | $19.9M | $9.7M | $46.7M | $23.6M | $18.8M | $29.3M | $11.4M | $21.4M | $11.3M | $12.3M | $13.8M | $16.3M | |||||
| Accounts Payable Current | $9.2M | $8.8M | $11.9M | $11.2M | $8.1M | $10.0M | $10.3M | $12.4M | $12.0M | $10.9M | $5.3M | $9.8M | $8.2M | $6.0M | $7.2M | $4.8M | $5.5M | $6.7M | |||||
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 | $25.0K | $282.0K | $86.0K | $343.0K | $52.0K | $254.0K | |||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $175.1M | -$26.2M | $142.0M | -$2.5M | -$69.2M | $118.8M | -$15.5M | ||||||||||||||||
| Allowance For Unbilled Receivables Current | $140.0K | $140.0K | $120.0K | $130.0K | $130.0K | $130.0K | $100.0K | $100.0K | $100.0K | $40.0K | $40.0K | $40.0K | $20.0K | $20.0K | $20.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Increase Decrease In Equity Securities Fv Ni | $48.2M | $5.7M | $53.5M | -$18.1M | $11.4M | $28.3M | $9.9M |
| Share Based Compensation | $43.0M | $49.9M | $47.8M | $39.6M | $26.5M | $10.5M | $2.2M |
| Proceeds From Sale And Maturity Of Marketable Securities | $354.6M | $361.8M | $384.0M | $364.7M | $392.7M | $138.8M | $57.2M |
| Payments To Acquire Property Plant And Equipment | $1.4M | $7.3M | $13.4M | $8.0M | $7.2M | $2.5M | $1.8M |
| Payments To Acquire Marketable Securities | $313.0M | $251.3M | $320.6M | $271.5M | $414.8M | $519.7M | $110.2M |
| Net Cash Provided By Used In Operating Activities | $13.9M | -$157.4M | -$136.7M | -$119.7M | -$70.7M | $16.8M | -$26.1M |
| Net Cash Provided By Used In Investing Activities | $57.9M | $148.8M | $193.0M | $90.0M | -$16.8M | -$381.7M | -$53.9M |
| Net Cash Provided By Used In Financing Activities | $2.9M | $10.1M | $9.0M | $2.1M | $8.0M | $541.3M | $28.7M |
| Increase Decrease In Unbilled And Other Receivables | $1.7M | -$3.5M | $10.0M | $4.3M | $5.2M | -$3.5M | $1.6M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.4M | $3.5M | $8.5M | $7.1M | $1.1M | -$187.0K | -$410.0K |
| Increase Decrease In Other Accrued Liabilities | $91.0K | -$1.9M | $5.9M | -$1.3M | $3.5M | -$1.2M | $958.0K |
| Increase Decrease In Employee Related Liabilities | -$2.8M | $10.3M | $6.9M | $6.5M | $6.4M | $5.0M | $2.9M |
| Increase Decrease In Accounts Receivable | -$152.7M | $169.7M | $10.0M | $23.7M | $321.0K | $12.7M | $5.0M |
| Increase Decrease In Accounts Payable | $908.0K | -$6.1M | $7.3M | $1.2M | -$411.0K | $4.9M | -$294.0K |
| Proceeds From Stock Options Exercised | $9.4M | $2.1M | $7.9M | $4.2M | $549.0K | ||
| Depreciation Depletion And Amortization | $6.0M | $6.2M | $5.6M | $4.3M | $2.8M | $3.7M | $3.6M |
| Payments To Acquire Equity Method Investments | $0.00 | $3.1M | $4.1M | $600.0K | $3.7M | $2.9M | |
| Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital | $0.00 | $0.00 | $147.2M | $11.8M | $375.0K | $4.6M | $943.0K |
| Increase Decrease In Operating Lease Liabilities | -$2.9M | -$5.4M | -$4.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Equity Securities Fv Ni | -$13.1M | $25.5M | -$5.8M | $8.1M | -$14.5M | $40.7M | $35.7M | $5.3M | -$15.7M | -$6.2M | -$627.0K | -$4.9M | $24.8M | $18.2M | $8.4M | -$3.1M | -$1.4M | $12.7M | -$627.0K |
| Share Based Compensation | $11.6M | $12.2M | $10.9M | $9.1M | $4.4M | $1.8M | $520.0K | ||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $58.8M | $46.3M | $127.4M | $99.5M | $66.5M | $42.9M | $6.3M | ||||||||||||
| Payments To Acquire Property Plant And Equipment | $596.0K | $4.1M | $3.6M | $1.7M | $513.0K | $843.0K | $1.1M | ||||||||||||
| Payments To Acquire Marketable Securities | $27.6M | $37.1M | $58.8M | $55.1M | $143.7M | $127.1M | $21.3M | ||||||||||||
| Net Cash Provided By Used In Operating Activities | $144.1M | -$39.3M | -$31.1M | -$39.7M | -$10.9M | -$5.8M | -$4.6M | ||||||||||||
| Net Cash Provided By Used In Investing Activities | $30.6M | $5.1M | $172.2M | $36.3M | -$61.9M | -$87.9M | -$16.1M | ||||||||||||
| Net Cash Provided By Used In Financing Activities | $409.0K | $8.0M | $867.0K | $908.0K | $3.7M | $212.5M | $5.2M | ||||||||||||
| Increase Decrease In Unbilled And Other Receivables | $6.3M | $2.7M | $336.0K | $7.4M | $3.1M | -$5.2M | -$973.0K | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $788.0K | $2.6M | $5.8M | $7.7M | $3.5M | $1.1M | -$87.0K | ||||||||||||
| Increase Decrease In Other Accrued Liabilities | -$228.0K | -$1.4M | $3.5M | $594.0K | $2.8M | -$638.0K | -$348.0K | ||||||||||||
| Increase Decrease In Employee Related Liabilities | -$20.6M | -$12.2M | -$11.7M | -$7.5M | -$1.7M | -$2.3M | -$685.0K | ||||||||||||
| Increase Decrease In Accounts Receivable | -$215.3M | -$46.2M | -$9.3M | -$2.9M | -$20.2M | -$2.4M | -$1.1M | ||||||||||||
| Increase Decrease In Accounts Payable | $1.3M | -$7.2M | $2.5M | $1.3M | -$1.2M | $2.1M | $1.0M | ||||||||||||
| Proceeds From Stock Options Exercised | $423.0K | $392.0K | $867.0K | $908.0K | $1.4M | $1.6M | $3.7M | $2.5M | $55.0K | $177.0K | $245.0K | $65.0K | $115.0K | ||||||
| Depreciation Depletion And Amortization | $1.6M | $1.4M | $1.8M | $969.0K | $887.0K | $877.0K | |||||||||||||
| Payments To Acquire Equity Method Investments | $0.00 | $4.1M | $0.00 | $2.9M | |||||||||||||||
| Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital | $0.00 | $111.3M | $0.00 | $40.0K | |||||||||||||||
| Increase Decrease In Operating Lease Liabilities | -$1.7M | -$2.0M | -$623.0K | $489.0K | -$1.4M | -$1.3M | -$1.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.41 | -$2.57 | $0.54 | -$2.10 | -$1.42 | -$0.41 | -$4.09 |
| Weighted Average Number Of Shares Outstanding Basic | 73.4M | 72.7M | 71.8M | 71.2M | 70.6M | 60.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 73.4M | 72.7M | 75.0M | 71.2M | 70.6M | 60.0M | |
| Earnings Per Share Basic | $-1.41 | $-2.57 | $0.57 | $-2.10 | $-1.42 | $-0.41 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.45 | -$0.59 | -$0.82 | -$0.52 | -$0.74 | -$0.76 | -$0.86 | $0.06 | $1.75 | -$0.56 | -$0.67 | -$0.48 | -$0.49 | -$0.49 | $0.00 | $0.05 | -$0.05 | -$0.34 | -$0.26 | -$0.01 | -$0.98 |
| Weighted Average Number Of Shares Outstanding Basic | 73.6M | 73.4M | 73.1M | 72.8M | 72.7M | 72.3M | 71.9M | 71.6M | 71.5M | 71.2M | 71.2M | 71.1M | 70.8M | 70.6M | 66.3M | 44.9M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 73.6M | 73.4M | 73.1M | 72.8M | 72.7M | 72.3M | 71.9M | 75.1M | 73.8M | 71.2M | 71.2M | 71.1M | 70.8M | 70.6M | 72.7M | 44.9M | |||||
| Earnings Per Share Basic | $-0.45 | $-0.59 | $-0.82 | $-0.52 | $-0.74 | $-0.76 | $-0.86 | $0.06 | $1.81 | $-0.56 | $-0.67 | $-0.48 | $-0.49 | $-0.49 | $0.06 | $-0.26 | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $3.0M | $1.5M | $9.4M | $2.1M | $7.9M | $4.2M | $549.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $43.0M | $49.9M | $47.8M | $39.6M | $26.5M | $10.5M | $2.2M |
| Prepaid Expense Current | $12.5M | $12.2M | $9.9M | $8.6M | $5.0M | $4.4M | $6.5M |
| Stock Issued During Period Shares Stock Options Exercised | 303.8K | 169.8K | 800.3K | 329.2K | 1.1M | 1.4M | 214.8K |
| Capital Expenditures Incurred But Not Yet Paid | $40.0K | $162.0K | $192.0K | $169.0K | $705.0K | $8.0K | $90.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $321.0K | $2.0M | $423.0K | $406.0K | $558.0K | $390.0K | $1.5M | $4.7M | $867.0K | $324.0K | $396.0K | $908.0K | $1.4M | $1.6M | $3.7M | $2.5M | $55.0K | $177.0K | $245.0K | $65.0K | $115.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.8M | $10.6M | $11.6M | $12.4M | $12.8M | $12.2M | $12.7M | $11.8M | $10.9M | $9.9M | $10.4M | $9.1M | $7.7M | $7.0M | $4.4M | $3.0M | $2.7M | $1.8M | $561.0K | $531.0K | $520.0K |
| Prepaid Expense Current | $13.3M | $14.9M | $12.6M | $13.1M | $15.5M | $12.3M | $13.1M | $14.0M | $11.4M | $9.1M | $12.1M | $11.5M | $5.5M | $7.3M | $8.0M | $4.4M | $5.3M | $5.9M | |||
| Stock Issued During Period Shares Stock Options Exercised | 34.9K | 193.2K | 52.8K | 57.5K | 149.8K | 252.9K | 587.1K | 908.6K | 16.7K | 57.6K | 95.3K | 25.0K | 44.2K | ||||||||
| Capital Expenditures Incurred But Not Yet Paid | $13.0K | $501.0K | $218.0K | $317.0K | $52.0K |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.